Get 40% Off
💰 Warren Buffett reveals a $6.72 billion stake in ChubbCopy Portfolios

Universal Health's (UHS) Q2 Earnings Top Estimates, Rise Y/Y

Published 07/25/2019, 11:25 PM
Updated 07/09/2023, 06:31 AM
MSFT
-
ELV
-
UNH
-
CNC
-
UHS
-

Universal Health Services Inc. (NYSE:UHS) delivered second-quarter 2019 adjusted earnings of $2.76 per share, beating the Zacks Consensus Estimate by 10.8%. Moreover, the bottom line improved 11.7% year over year and this upside is mainly attributable to rising revenues.

Further, net revenues increased 6.5% year over year to $2.8 billion and also exceeded the Zacks Consensus Estimate by 1.6%, backed by higher admissions and patient days.

Total operating expenses of $2.5 billion at the end of the second quarter increased 6.5% year over year, mainly due to salaries, wages and benefits along with other operating expense plus supplies expenses.

Segmental Update

Acute Care Hospitals:


Adjusted admissions and adjusted patient days rose 5% and 5.2%, respectively, from the prior-year quarter. Net revenues (on a same-facility basis) climbed 9% in the second quarter, majorly aided by higher admissions and patient days.

Behavioral Hospitals:

On same-facility basis, adjusted admissions inched up 0.5% while adjusted patient days dipped 0.3%, both on a year-over-year basis. Net revenues were up 2.7% during the quarter under review on same-facility basis owing to higher admissions.

Financial Update

As of Jun 30, 2019, the company had cash and cash equivalents of nearly $61.3 million, up 41.7% from the level at 2018 end.

Total assets were $11.8 billion as of Jun 30, 2019, up 4.3% from the 2018-end figure.

The company’s long-term debt came in at $4 billion, up 3.1% from the level at 2018 end.

For the first six months of 2019, net cash provided by operating activities totaled $624 billion, up 2.8% year over year.

Buyback Program

In the second quarter, the company bought back 2.72 million shares worth $339.2 million.

In July 2019, the company’s board of directors increased its share buyback plan by $1 billion.

The company’s cash dividend was hiked from 10 cents to 20 cents per share in July, 2019. This meatier dividend will be paid out on Sep 16, 2019 to shareholders of record on Sep 3, 2019.

Zacks Rank

Universal Health currently carries a Zacks Rank #4 (Sell).

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Releases From the Medical Sector

Among other players from the medical sector having reported second-quarter earnings so far, the bottom-line results of UnitedHealth Group Incorporated (NYSE:UNH) , Anthem Inc. (NYSE:ANTM) and Centene Corporation (NYSE:CNC) outpaced the respective Zacks Consensus Estimate.

Biggest Tech Breakthrough in a Generation

Be among the early investors in the new type of device that experts say could impact society as much as the discovery of electricity. Current technology will soon be outdated and replaced by these new devices. In the process, it’s expected to create 22 million jobs and generate $12.3 trillion in activity.

A select few stocks could skyrocket the most as rollout accelerates for this new tech. Early investors could see gains similar to buying Microsoft (NASDAQ:MSFT) in the 1990s. Zacks’ just-released special report reveals 7 stocks to watch. The report is only available for a limited time.

See 7 breakthrough stocks now>>



UnitedHealth Group Incorporated (UNH): Free Stock Analysis Report

Anthem, Inc. (ANTM): Free Stock Analysis Report

Centene Corporation (CNC): Free Stock Analysis Report

Universal Health Services, Inc. (UHS): Free Stock Analysis Report

Original post

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.